[Mixed infection after renal transplantation (author's transl)].
Severe mixed infection was observed in 9 out of 101 renal transplant recipients over a period of 6 years and was characterized by the simultaneous incidence of bacterial, fungal and viral infections. Severe septicaemia was clinically evident in all cases. The critical clinical situation called for a rapid assessment of the differential diagnosis and relevant bacterial, fungal and viral investigations. Antibacterial and antimycotic therapy must be instituted as soon as possible on account of the high mortality from mixed infection in renal transplant recipients. The reduction or discontinuation of immunosuppressive therapy during infection did not impair renal transplant function.
D001424:Bacterial Infections / Q000209:etiology; D005260:Female; D005839:Gentamicins / Q000627:therapeutic use; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects*; D016030:Kidney Transplantation; D008297:Male; D008825:Miconazole / Q000627:therapeutic use; D009181:Mycoses / Q000209:etiology; D009761:Nystatin / Q000627:therapeutic use; D014184:Transplantation, Homologous; D014777:Virus Diseases / Q000209:etiology
D005839:Gentamicins; D009761:Nystatin; D008825:Miconazole
Mehrfachinfektionen nach Nierrentransplantation.